Related Experiment Video

Updated: Aug 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Does statin therapy influence steroid hormone synthesis?

M Böhm1, W Herrmann, S Wassmann

  • 1Klinik für Innere Medizin III, Universitätskliniken des Saarlandes, Kirrberger Strasse, 66421 Homburg, Germany. boehm@med-in.uni-saarland.de

Zeitschrift Fur Kardiologie
|January 24, 2004
PubMed

Insights

Pravastatin effectively lowers LDL cholesterol but does not significantly alter levels of key steroid hormones or gonadotropins in patients. This study confirms statin therapy

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins are known to inhibit cholesterol biosynthesis.
  • Cholesterol is a precursor for steroid hormone synthesis.
  • The impact of statins on steroid hormone and gonadotropin levels requires clarification.

Purpose of the Study:

  • To investigate the effect of pravastatin on plasma concentrations of steroid hormones and gonadotropins.
  • To determine if pravastatin alters estradiol, testosterone, cortisol, dehydroepiandrosterone sulfate (DHEAS), FSH, and LH levels.

Main Methods:

  • A randomized, placebo-controlled trial involving 22 patients.
  • Patients received either pravastatin (40 mg/day) or a placebo.
  • Measurements included total cholesterol, LDL cholesterol, steroid hormones, and gonadotropins (FSH, LH).

Main Results:

  • Pravastatin significantly reduced total and LDL cholesterol levels.
  • No significant changes were observed in plasma concentrations of estradiol, testosterone, cortisol, or DHEAS.
  • Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels remained unchanged.

Conclusions:

  • Pravastatin, at a clinically relevant dose, does not significantly affect steroid hormone or gonadotropin levels.
  • The cholesterol-lowering effects of pravastatin are not associated with alterations in these key endocrine markers.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...